The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells
eLife · 2025
DOI: 10.7554/elife.102681 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Haibin Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, CCR/NCI/NIH, Frederick, United States. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Uterine Cervical Neoplasms, Human papillomavirus 16, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Intramural NIH HHS, The Intramural Research Program of the NIH, NCI, Center for Cancer Research.
Abstract (Originalsprache)
Increased expression of lnc-FANCI-2, a newly discovered long noncoding RNA, is associated with cervical lesion progression from cervical intraepithelial neoplasia stage 1 (CIN1, low grade), CIN2–3 (high grade), to cervical cancer. Viral oncoprotein E7 of high-risk human papillomaviruses (HR-HPVs) and host transcription factor YY1 are two major factors promoting lnc-FANCI-2 expression. Using CRISPR-Cas9 technology, we knocked out the expression of lnc-FANCI-2 in the HPV16-positive cervical cancer cell line, CaSki cells. The selected knockout (KO) single-cell clones displayed altered cell morphology and proliferation with changes of cellular soluble receptors, but normal HPV16 E6 and E7 expression. Relative to the parental cells, lnc-FANCI-2 KO cells exhibited significantly increased RAS signaling and epithelial-mesenchymal transition, but decreased response to IFN signaling, along with increased p-Akt and p-Erk1/2 (two RAS signaling effectors), IGFBP3, MCAM, VIM, and CCND2 (cyclin D2) and decreased expression of RAC3. lnc-FANCI-2 in CaSki interacts with cellular proteins H13, HNRH1, K1H1, MAP4K4, and RNPS1. MAP4K4 knockdown led to enhance the expression of p-Erk1/2 and p-Akt. High lnc-FANCI-2 and low MCAM levels in cervical cancer tissues were found to be associated with patients’ survival. A key function of lnc-FANCI-2 intrinsically regulates RAS signaling to impact cervical lesion progression and cervical cancer prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, CCR/NCI/NIH, Frederick, United States.
- Collaborative Bioinformatics Resource, CCR/NCI/NIH, Bethesda, United States.
- NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, United States.
- Mouse Cancer Genetics Program, CCR/NCI/NIH, Frederick, United States.
- Laboratory of Cellular Oncology, CCR/NCI/NIH, Bethesda, United States.
ORCID-Profile: Haibin Liu, Lulu Yu, Zhi-Ming Zheng
Förderung
- Intramural NIH HHS
- The Intramural Research Program of the NIH, NCI, Center for Cancer Research
Zitieren
APA
Liu, H., Yu, L., Majerciak, V., Meyer, T. J., Yi, M., Johnson, P. F., Cam, M., Lowy, D. R., & Zheng, Z. M. (2025). The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells. eLife. https://doi.org/10.7554/elife.102681
Vancouver
Liu H, Yu L, Majerciak V, Meyer TJ, Yi M, Johnson PF, et al. The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells. eLife. 2025. doi:10.7554/elife.102681
BibTeX
@article{Liu2025,
author = {Liu, Haibin and Yu, Lulu and Majerciak, Vladimir and Meyer, Thomas J and Yi, Ming and Johnson, Peter F and Cam, Maggie and Lowy, Douglas R and Zheng, Zhi-Ming},
title = {The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.102681}
}
EUVIMED